User profiles for J.J. Knox
 | Jennifer KnoxMedical Oncology, Princess Margaret Cancer Center, University of Toronto Verified email at uhn.ca Cited by 33737 |
Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis
…, R Leibowitz-Amit, G Sonpavde, JJ Knox… - Journal of the …, 2014 - academic.oup.com
Background Inflammation may play an important role in cancer progression, and a high
neutrophil-to-lymphocyte ratio (NLR) has been reported to be a poor prognostic indicator in …
neutrophil-to-lymphocyte ratio (NLR) has been reported to be a poor prognostic indicator in …
[HTML][HTML] Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis
The authors concluded that their analyses supported additional therapy after surgery, for
high-risk patients with biliary tract cancers. These conclusions appear to reflect the evidence, …
high-risk patients with biliary tract cancers. These conclusions appear to reflect the evidence, …
Systemic therapy for non–clear cell renal cell carcinomas: a systematic review and meta-analysis
… Knox a , Ian F. Tannock a , Bernard Escudier d , Eitan Amir a … Knox receives research
funding from Pfizer, Novartis, and Astra-Zeneca. Eitan Amir receives honoraria from Pfizer. The …
funding from Pfizer, Novartis, and Astra-Zeneca. Eitan Amir receives honoraria from Pfizer. The …
[PDF][PDF] Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor–targeted agents: results …
…, T Cheng, S North, P Venner, JJ Knox… - Journal of clinical …, 2009 - imdconline.com
… Knox, Kim N. Chi, Christian Kollmannsberger, David F. McDermott, William K. … Knox,
Pfizer, Novartis, Bayer Pharmaceuticals; Ronald M. Bukowski, Bayer Pharmaceuticals, Pfizer …
Pfizer, Novartis, Bayer Pharmaceuticals; Ronald M. Bukowski, Bayer Pharmaceuticals, Pfizer …
Efficacy and safety of nivolumab plus ipilimumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib: the CheckMate 040 …
… Dr Knox reported grants from Ipsen and grants and personal fees from AstraZeneca, Merck,
and F. Hoffman-La Roche outside the submitted work. Dr El-Rayes reported grants and …
and F. Hoffman-La Roche outside the submitted work. Dr El-Rayes reported grants and …
Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma
…, B Cummings, J Sykes, M Sherman, JJ Knox… - Journal of Clinical …, 2013 - ascopubs.org
Purpose To describe outcomes of prospective trials of stereotactic body radiotherapy (SBRT)
for hepatocellular carcinoma (HCC). Patients and Methods Two trials of SBRT for patients …
for hepatocellular carcinoma (HCC). Patients and Methods Two trials of SBRT for patients …
[PDF][PDF] Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses
…, OY Soliman, M Pine, P Hicks, TB Manzoni, JJ Knox… - Immunity, 2021 - cell.com
Adjuvants are critical for improving the quality and magnitude of adaptive immune responses
to vaccination. Lipid nanoparticle (LNP)-encapsulated nucleoside-modified mRNA …
to vaccination. Lipid nanoparticle (LNP)-encapsulated nucleoside-modified mRNA …
Systemic therapy for advanced hepatocellular carcinoma: ASCO guideline
…, A Karippot, AO Kaseb, RK Kelley, JJ Knox… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE To develop an evidence-based clinical practice guideline to assist in clinical
decision making for patients with advanced hepatocellular carcinoma (HCC). METHODS ASCO …
decision making for patients with advanced hepatocellular carcinoma (HCC). METHODS ASCO …
[PDF][PDF] Phase I study of individualized stereotactic body radiotherapy of liver metastases
…, J Ringash, RV Tse, JJ Knox… - Journal of clinical …, 2009 - scholar.archive.org
… Knox, and Laura A. Dawson … Knox, Laura A. Dawson … Knox, Laura A. Dawson Final
approval of manuscript: Mark T. Lee, John J. …
approval of manuscript: Mark T. Lee, John J. …
Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma …
… Knox e , Georg A. Bjarnason f , Sumanta Kumar Pal g , Christian K. Kollmannsberger h ,
Takeshi … Knox is a consultant for Aveo and receives research funding from Pfizer. Georg A. …
Takeshi … Knox is a consultant for Aveo and receives research funding from Pfizer. Georg A. …
